Summary & Overview
CPT 15011: Skin Cell Suspension Autograft Harvest, ≤25 sq cm
CPT code 15011 describes harvesting epidermal and dermal skin for a skin cell suspension autograft (SCSA), covering the first 25 square centimeters or less. This code captures a specialized surgical step in autograft preparation used in reconstructive and wound-care settings. Nationally, accurate coding for SCSA harvests matters for clinical documentation, interfacility billing consistency, and proper classification of operative services.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for SCSA harvesting, typical sites of service, and which payers commonly adjudicate claims for this code. The publication provides benchmarks for utilization and coverage trends, summaries of relevant policy language where available, and guidance on common modifier usage and billing scenarios. Data limitations are noted where input fields are incomplete.
This summary is intended for clinicians, coding professionals, and policy analysts seeking a national-level briefing on the role and billing implications of CPT code 15011 within surgical and wound-care practice settings.
Billing Code Overview
CPT code 15011 describes a service in which the provider harvests epidermal and dermal skin to create a skin cell suspension autograft (SCSA). This code specifically represents the initial 25 square centimeters or less of harvested donor skin.
-
Service type: Surgical skin harvest for autograft preparation
-
Typical site of service: Operating room or procedure suite where surgical skin harvesting and preparation for autograft are performed
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a full-thickness or deep partial-thickness skin defect from thermal injury, traumatic wound, or a chronic nonhealing ulcer where a skin cell suspension autograft (SCSA) is indicated to restore epidermal coverage. The patient presents to an outpatient surgical center or hospital operating room after initial wound bed preparation and debridement. Preoperative planning includes assessment of wound size (to confirm the graft area is 25 sq cm or less for 15011), donor site selection, informed consent, and optimization of comorbid conditions such as diabetes or peripheral vascular disease. In the OR, the surgeon harvests a small split-thickness epidermal and dermal sample, processes it into a cellular suspension, and applies the suspension to the prepared wound. Postoperative workflow includes dressing application, instructions for offloading and wound care, scheduled follow-up visits for graft take assessment, and documentation of graft dimensions and donor site care. Typical sites of service are outpatient surgical centers, hospital outpatient departments, or inpatient operating rooms for more complex cases.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the work, time, or complexity substantially exceeds typical for 15011 and documentation supports increased services. |